A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

Clinical trial NCT06593522 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06593522
Sponsor: Amgen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

MTAP-deleted NSCLC

Start date: 2024-12-26
Primary completion: 2026-10-31
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.